Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter Study to Evaluate the Pharmacokinetics and Safety of EXPAREL in Pediatric Subjects
2020-005985-33Phase 3
- Sponsor
- Pacira BioSciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bupivacaine in Persistent postsurgical pain (PPSP), sponsored by Pacira BioSciences. Primary endpoint: Pharmacokinetic parameters of EXPAREL.
02
Drugs
bupivacaine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on 2020-005985-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005985-33.